NurExone’s U.S. subsidiary, Exo-Top Inc., is advancing plans for the establishment of a GMP-compliant facility dedicated to naive exosome production. The Company believes participation in ARMI’s ...
NurExone Biologic Inc. has been accepted into the BioFab Startup Lab, part of the Advanced Regenerative Manufacturing Institute’s BioFabUSA program, which supports early-stage biotech companies in ...
On Thursday, Oct. 30, the band Armistead’s Armi marches to Northside Grille, with a spooky-themed song or two up its sleeve ...
Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Note: Hover over the donut graph to view ...
New research from the Australian Regenerative Medicine Institute (ARMI) at Monash University has identified novel cell types and RNA signals that may assist with brain and spinal cord repair. Tissues ...
SEATTLE--(BUSINESS WIRE)--Pluristyx, Inc. today announced an agreement with the Advanced Regenerative Manufacturing Institute | BioFabUSA to manufacture and commercialize Pluristyx’s clinical-grade ...
SEATTLE--(BUSINESS WIRE)--Pluristyx, Inc., a leading chemistry, manufacturing, and controls (CMC), consulting, process development, and tools provider for cell and gene therapy companies, today ...
Scientists have uncovered a key step in the wound healing process that becomes disabled in diseases like diabetes and ageing, contributing to a global healthcare cost of managing poorly healing wounds ...
The innate immune response is known to impact early stages of wound repair, with the role of some sensory neurons, including nociceptors, established as immunoregulators. However, the extent of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback